Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Melanoma 70Skin Neoplasms 17Carcinoma, Basal Cell 16Lymphoma, T-Cell, Cutaneous 12Neoplasms 9Keratosis, Actinic 8Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 6Carcinoma, Squamous Cell 6Carcinoma, Merkel Cell 6Mycosis Fungoides 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Breast Neoplasms 5Uveal Melanoma 4Sezary Syndrome 4Neoplasm Metastasis 4Uterine Cervical Neoplasms 3Sarcoma 3Endometrial Neoplasms 3Urogenital Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Neoplasms 2Testicular Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2

Interventions

3-(3'-adamantan-1-yl-4'-methoxybiphenyl-4-yl)-2-propenoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Thyroid cancer, medullary × Dermatologic × Clear all
NCT07252661 2025-11-28

Study of ACC-1898 in Adult Participants With Advanced Solid Tumors

AccSalus Biosciences, Inc.

Phase 1 Not yet recruiting
40 enrolled
DermatologicEndocrineGastrointestinalGenitourinaryHead & Neck

Thyroid cancer, medullary, Carcinoma, Renal Cell, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡